Journal
DRUG DISCOVERY TODAY
Volume 18, Issue 3-4, Pages 128-140Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2012.08.002
Keywords
-
Categories
Funding
- National Institutes of Health [RO1 CA138791, U54 CA163120, EDRN UO1 CA111294]
- U.S. Department of Defense [PC074289]
Ask authors/readers for more resources
The in vivo zebrafish models have recently attracted great attention in molecular oncology to investigate multiple genetic alterations associated with the development of human cancers and validate novel anticancer drug targets. Particularly, the transparent zebrafish models can be used as a xenotransplantation system to rapidly assess the tumorigenicity and metastatic behavior of cancer stem and/or progenitor cells and their progenies. Moreover, the zebrafish models have emerged as powerful tools for an in vivo testing of novel anticancer agents and nanomaterials for counteracting tumor formation and metastases and improving the efficacy of current radiation and chemotherapeutic treatments against aggressive, metastatic and lethal cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available